Graticule appoints David Legge as Director of Business Development
NEWTON, Mass.–(BUSINESS WIRE)–Graticule, a Real-world data CRO that conducts life science research and development projects with US and international data partners, announces the onboarding of David Legge as Director of Business Development.
Daniel Poscover, Founder and CEO of Graticule, said, “With 25 years of experience in identifying opportunities and executing visionary strategies, I’m confident he will work closely with our clients to understand their RWE study challenges, and help us provide innovative solutions.”
David served as a Business Development Manager at TriNetX for nearly a decade, where he played a pivotal role in fostering growth. Before this, he honed his skills as a Business Development Representative at Recombinant Data, working alongside Graticule CTO Dan Housman. Notably, Recombinant Data Corp, a bootstrapped company was acquired by Deloitte in 2012, where he continued as a Business Development Manager until 2014.
Dan Housman, Co-Founder and CTO of Graticule, quoted, “David’s role at Graticule marks the reuniting of our partnership. David will help us foster collaboration with clients and enable us to apply our capabilities to address their life sciences challenges.”
To learn more, visit Graticule.
Graticule is a Real-World Data CRO conducting life science research and development projects with USA and International data partners. The company focuses on establishing relationships, tools, and expertise to overcome traditional barriers that have limited the applications of medical data. Graticule solutions include comparative effectiveness studies, surveillance, patient identification, clinical trial recruitment, and an automated data transfer to Electronic Data Capture systems. The company differentiates itself by focusing on timely access to relevant patient data through close engagement with the Graticule Research Network and project-specific data partners. The result of the approach is a team that can rapidly leverage advanced data sets such as clinical notes, imaging, genetic testing, and structured clinical data and can scale research to large populations over time. Our solutions include Graticule Study Source, Graticule Patient Finder, and Graticule CLEHR.